loading...| Preferred Name |
Ulipristal |
|
| Synonyms |
11-beta-(4-(dimethylamino)phenyl)-17-hydroxy-19-norpregna-4,9-diene-3,20-dione ULIPRISTAL Ulipristal |
|
| Definitions |
A selective progesterone receptor modulator with anti-progesterone activity. Ulipristal binds to the progesterone receptor (PR), thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system. As a result, this agent may suppress the growth of uterine leiomyomatosis. Furthermore, by inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C91056 |
|
| CAS_Registry |
159811-51-5 |
|
| Chemical_Formula |
C28H35NO3 |
|
| code |
C91056 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
A selective progesterone receptor modulator with anti-progesterone activity. Ulipristal binds to the progesterone receptor (PR), thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system. As a result, this agent may suppress the growth of uterine leiomyomatosis. Furthermore, by inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception. |
|
| FDA_UNII_Code |
6J5J15Q2X8 |
|
| FULL_SYN |
11-beta-(4-(dimethylamino)phenyl)-17-hydroxy-19-norpregna-4,9-diene-3,20-dione ULIPRISTAL Ulipristal |
|
| label |
Ulipristal |
|
| Preferred_Name |
Ulipristal |
|
| prefixIRI |
Thesaurus:C91056 |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0300205 |
|
| subClassOf |